G-CSF therapy to boost AMH: rewriting the advanced fertility dilemma
Introduction: An ice-breaking discovery in the global aging fertility dilemma At a time when the global natural pregnancy rate of women over 40 years old is less than 5%, a groundbreaking clinical study in Japan has brought light to the group with declining ovarian function. The study found that two consecutive luteal phase injections of granulocyte colony-stimulating factor (G-CSF) during the luteal phase of the menstrual cycle increased serum AMH levels by an average of 63% and increased the cumulative live birth rate of in vitro fertilization (IVF) from 14% to 32%. This discovery not only overturns the traditional perception of ovarian aging, but also may reshape the landscape of assisted reproduction treatment. I.A Scientific Breakthrough Inspired by Accident: From Endometrial Repair to Ovarian Recovery Initial application scenario: G-CSF was originally used to improve the embryo implantation rate in patients with thin endometrium, but it triggered an unexpected harvest in 10 patients with diminished ovarian reserve (DOR) – 3 cases became pregnant naturally within 2 months after treatment, including a 45-year-old twin pregnancy.Animal model validation: Rat experiments showed a 40% increase in the number of primordial follicles and a 55% decrease in apoptosis in the G-CSF treatment group, confirming its regenerative potential on ovarian reserve. Study architecture: 100 elderly women (mean age 39.5 years) with AMH <1.1 ng/ml were randomized into a G-CSF group (50 cases) versus a control group (50 cases).Intervention program:G-CSF group: 300 μg G-CSF was injected subcutaneously on day 21 of the menstrual cycle for 2 consecutive cycles.Control group: standard IVF regimen without additional intervention. II.the data shock: the efficacy far exceeds the expected all-round improvement norm G-CSF group (n=45) Control group (n=44) Enhancement Change in AMH levels +63% -12% 75%↑ Number of eggs acquired/cycle 6.2 5.1 22%↑ blastocyst formation rate 57% 29% 97%↑ Cumulative live birth…